Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Amoxicillin vs Ampicillin for Severe Pneumonia in Children
NCT03369093Completed
- Sponsor
- icddr,b
- Start
- Jan 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amoxicillin in pneumonia (2 arms), sponsored by icddr,b. Primary endpoint: Treatment failure at 48 hours. Started Jan 2018; status: completed.
02
Drugs
amoxicillin
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT03369093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369093.